In a landmark decision, Canada has legalized the medical use of psychedelics like psilocybin (found in magic mushrooms) and MDMA for treating depression, PTSD, and anxiety under professional supervision.
The Canadian Health Ministry stated that evidence from clinical trials shows significant improvements in mental health conditions that resisted conventional treatments.
This move is closely watched by mental health professionals globally, including those in South Asia where rates of depression and PTSD are rising, highlighting the need for innovative treatments.